Previous Article | Next Article ![]()
Journal of Virology, October 2006, p. 9934-9942, Vol. 80, No. 20
0022-538X/06/$08.00+0 doi:10.1128/JVI.01112-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Doris Lengenfelder,
Monika Schmidt,
Ingrid Müller-Fleckenstein,
Bernhard Fleckenstein,
Armin Ensser,
and
Brigitte Biesinger
*
Institut für Klinische und Molekulare Virologie, Friedrich-Alexander Universität Erlangen-Nürnberg, D-91054 Erlangen, Germany
Received 31 May 2006/ Accepted 24 July 2006
|
|
|---|
|
|
|---|
B (12, 30, 38, 45, 55, 63). In accordance with the T-cell phenotype of the tumors in transgenic mice, Tip directly binds to the Src family tyrosine kinase Lck, which is a key regulator of T-cell activation (7, 37). The strong interaction of Tip with Lck relies on the Lck binding domain (LBD), consisting of a 9-amino-acid motif with homology to the C termini of various Src family kinase domains (CSKH), a 20-amino-acid linker, and a 9-amino-acid proline-rich consensus sequence for SH3 domain binding (SH3B) (7, 39). In addition, a phosphotyrosyl peptide corresponding to tyrosine residue Y127 of Tip-C488, but not the one corresponding to Y114, was identified as a ligand for the SH2 domain of Lck in a biophysical assay (4). As the related positions of Tip-C484 (tyrosine residues Y72 and Y85, respectively) are substrates for Lck in transiently transfected 293T cells (32), phosphorylated Y85/Y127 might indeed represent a third Tip-Lck interaction site, but binding of full-length Tip to the Lck SH2 domain remains to be demonstrated.
Tip was also found to associate with signal transducers and activators of transcription 1 and 3 (STAT1/3) in cells expressing Lck (50). The interaction depends on tyrosine residue Y72 of Tip-C484, which is embedded in a STAT SH2 binding motif (YXPQ) conserved at position Y114 of Tip-C488 (32). These findings suggest that Tip, phosphorylated at position Y72/Y114 by Lck, binds to the SH2 domains of STAT1 and STAT3. Recruitment by Tip and subsequent phosphorylation by Lck provide an explanation for the observed activation of STAT1 and STAT3 in the presence of Tip and Lck (32, 42, 50, 51, 60). The implication of constitutively active STATs, especially STAT3, in growth regulation and oncogenesis in multiple cell types (8, 10) suggested a central role for Tip-induced STAT activity in viral T-cell transformation. However, recombinant herpesvirus saimiri C488 expressing Tip with a tyrosine-to-phenylalanine substitution at position 114 was able to transform primary human T lymphocytes in the absence of STAT1 or STAT3 activation (35). Thus, the essential function of Tip in lymphocyte transformation does not rely on Lck-mediated STAT1/3 phosphorylation.
Given the central role of Lck in T-cell activation, Tip was assumed to activate T-cell proliferation by inducing the kinase and thus mimicking T-cell receptor (TCR) ligation. In accordance with this hypothesis, several studies demonstrated a strong activation of Lck in the presence of Tip, which is achieved by cooperation of the CSKH and SH3B motifs within the LBD independently of regulatory tyrosine phosphorylation of Lck (32, 33, 42, 48, 51, 67). However, overexpression of Tip-C488 downregulated stimulation-induced cellular protein tyrosine phosphorylation in Jurkat T cells and partially reversed the phenotype of fibroblasts transformed by a constitutively active mutant of Lck (40). These effects were even enhanced when tyrosine residue Y114 in Tip-C488 was replaced by serine (Tip Y114S) (29). An explanation for these seemingly contradictory observations is provided by analyses of surface receptor levels on Tip-expressing T cells. As previously described for constitutively active Lck (19), Tip and, more prominently, Tip Y114S downregulate TCR/CD3 from the surfaces of T cells (29, 58, 59). Receptor modulation is caused by Lck-dependent endocytosis and involves a lysosomal 80-kDa protein binding to the C terminus of Tip, which targets the Lck-receptor complex to enlarged endosomal vesicles for subsequent degradation (58, 59). This process results in reduced levels of Lck and, by intracellular sequestration of signaling components, may account for the Tip-mediated block in signal transduction from the TCR to Zap70 (11). Another negative regulatory mechanism was described for lymphocytes transduced with Tip-expressing lentiviral vectors; in conjunction with Lck, Tip promotes Fas-mediated apoptosis (34). Taken together, overexpression of Tip in T cells appears to induce Lck activity, which in turn triggers feedback mechanisms that restrict cellular activation.
While all effects of Tip observed so far in transfected or transduced T cells depend on Lck, Duboise and colleagues (21) reported transformation and oncogenesis by herpesvirus saimiri C488 to be independent of Tip's ability to bind to the kinase. In their study, mutation of the SH3B motif was considered sufficient to abrogate Tip-Lck interaction, an assumption questioned by subsequent reports on residual Lck binding and activation by Tip mutated either at the SH3B or at the CSKH motif (31) and on a putative third Tip-Lck interaction site constituted by phosphorylation of tyrosine residue 127 (4).
To further analyze the role of the indiviual Tip-Lck interaction sites in viral T-cell transformation, we first tested all Tip mutants used for the ability to bind to Lck. Then, we introduced the same mutations into the viral genome and used the recombinant viruses to infect human cord blood lymphocytes (CBL). Both LBD motifs of Tip, CSKH and SH3B, were found to be required for growth transformation of human T cells, although their individual mutation did not completely abrogate Lck binding activity. Mutation of tyrosine residue Y127 of Tip did not reduce Lck binding in the presence of an intact LBD but interfered with the capability of recombinant virus to transform T cells in the absence of exogenous interleukin-2 (IL-2). Taken together, our data demonstrate that growth transformation by herpesvirus saimiri depends on a complex interaction of Tip with the T-cell tyrosine kinase Lck.
|
|
|---|
CSKH (deletion of 146EDLQSFLEK154), pBKCMVAU-1-Tip/mSH3B (175PTPPLPPRP183 mutated to ATAALAARA), or pBKCMVAU-1-Tip/
CSKHmSH3B (double mutant) (39) were transferred into the EcoRI and XhoI restriction sites of expression vector pcDNA3 (Invitrogen, Karlsruhe, Germany). For the expression of Tip with an amino-terminal hemagglutinin (HA) epitope, tip sequences were PCR amplified from plasmids pSTBlueStpCTip (35) or pSTBlueStpCTip-FFYF (pSTBlueStpCTip with tyrosine-to-phenylalanine substitutions at amino acid positions 94, 114, and 155 of Tip) with primers generating BglII and KpnI restriction sites and ligated into pcDNA-HA-MH (61). The cDNA sequence encoding the full-length human lck tyrosine kinase (the plasmid was kindly provided by R. M. Perlmutter, Seattle, WA) was subcloned into the pFJ vector (39). The expression plasmid for the SH3 deletion mutant of Lck was generated by ligating the BsgI/MscI-cleaved pFJ construct with two complementary oligonucleotides (5' ACCTGGTGG 3' and 5' CCACCAGGTTG 3'), thereby removing the coding sequences for amino acids 67 to 115.
Generation of recombinant viruses. The herpesvirus saimiri C488 mutant HVS/Tip mSH3B (21) was obtained from J. U. Jung (Southborough, MA). All other virus recombinants were generated by a cosmid-based approach as described previously (35). The specific mutations in the LBD of the tip gene were introduced into pSTBlueStpCY114HN by insertion of XhoI-StuI fragments excised from the pBKCMVAU-1-Tip plasmids (39). Furthermore, tyrosine residue 127 was replaced by phenylalanine through PCR mutagenesis of plasmid pSTBlueStpCTip using the oligonucleotides y127f1 (5'-GAACAAGCTGTTCAAGTTTGTTAGC-3') and y127f2 (5'-ACAACTTTTGAAGACGCAAGGGC-3'). Mutated Bst1107I fragments were reinserted into cosmid 331, which was then used to reconstitute replication-competent viral genomes as described previously (35).
DNA sequence analysis. Nucleotide sequences of expression plasmids and virus recombination intermediates were determined with an ABI PRISM 3100 Genetic Analyzer according to the manufacturer's instructions (Applied Biosystems, Darmstadt, Germany). DNA sequence evaluation was done with the GAP4 software (Staden Package [14]).
Cell culture and transfection. OMK cells (ATCC CRL1556) were used to propagate herpesvirus saimiri. The cells were cultivated in Dulbecco's modified Eagle's medium supplemented with glutamine (350 µg/ml), gentamicin (100 µg/ml), and 10% heat-inactivated fetal calf serum (FCS) (Biochrom, Berlin, Germany). Virus stocks were generated by infection of confluent OMK cells at a low multiplicity of infection.
Human lymphocyte cultures were grown in RPMI 1640 (Invitrogen) and Panserin 401 medium mixed at a ratio of 1:1 supplemented with 10% irradiated FCS (Pan Biotech, Aidenbach, Germany), glutamine (350 µg/ml), and gentamicin (100 µg/ml). Callithrix jacchus T-cell lines transformed by herpesvirus saimiri wild-type strain C488 (17) or by mutant HVS/Tip mSH3B, kindly provided by J. U. Jung (21), were maintained in a mixture of 50% CG medium (Vitromex, Selters, Germany) and 50% RPMI 1640 medium containing 10% FCS.
Jurkat clone E6-1 cells (ATCC TIB-152) were maintained in RPMI 1640 supplemented with 10% FCS. For transient transfection, 107 Jurkat cells were mixed with 30 to 95 µg plasmid DNA, electroporated by a single pulse of 250 V and 1,500 µF, and harvested after 24 to 48 h (EasyJect; Equibio).
COS-7 cells (27) were grown in Dulbecco's modified Eagle's medium containing 10% FCS. A DEAE-dextran procedure was used for transient transfection (62). Transfected COS-7 cells were grown for 24 to 48 h; washed twice with phosphate-buffered saline, pH 7.4 (PBS); harvested; and stored as cell pellets at 80°C.
Lymphocyte transformation. Human CBL were isolated by selective sedimentation of erythrocytes for 45 min at 37°C in 5% dextran (molecular weight, 250,000) and 150 mM NaCl. Primary cells were washed with PBS and stimulated with 1 µg/ml phytohemagglutinin in cell culture medium. Ten units/ml exogenous IL-2 (Roche Diagnostics, Mannheim, Germany) was added after 24 h. On the next day, the cells were infected as described previously (24). Five days after infection, the cells were split into two cultures, and exogenous IL-2 was depleted from one of the cultures by centrifugation and washing of the cells. Cell culture densities were determined by automated cell counting (Micro Cell Counter F-300 [Sysmex, Norderstedt, Germany]; Beckman-Coulter [Krefeld, Germany] Z2). Growth transformation was assessed microscopically and by the observation of accelerated growth over a period of at least 3 months postinfection. Transformed T-cell lines were analyzed by PCR and restriction mapping to confirm the presence of the specific viral genotype.
Antibodies and antisera. Rabbit antisera directed against Tip were kindly provided by J. U. Jung (Southborough, MA) and A. Y. Tsygankov (Philadelphia, PA) or generated by immunization with partially purified Tip (amino acids 1 to 226) (66). Rabbit polyclonal and mouse monoclonal anti-Lck were purchased from BD Biosciences (Heidelberg, Germany), and a guinea pig antiserum was generated by immunization with a glutathione S-transferase fusion protein of the Lck-unique domain (amino acids 1 to 61). Mouse monoclonal AU1 antibody was purchased from BAbCo (Richmond, CA). The CD4-specific mouse monoclonal antibody 16H5 was a generous gift of Frank Emmrich (Leipzig, Germany). Phosphotyrosine antibody 4G10 was obtained from Biomol (Hamburg, Germany). Horseradish peroxidase-conjugated secondary antibodies were purchased from DAKO (Hamburg, Germany) and Medac (Hamburg, Germany).
Immunoprecipitation and immunoblotting. Cells were lysed in TNE (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 2 mM EDTA, 1% NP-40) supplemented with 1 mM sodium orthovanadate (Na3VO4), 5 mM NaF, 10 µg/ml aprotinin, and 10 µg/ml leupeptin (Sigma-Aldrich, Taufkirchen, Germany). For immunoprecipitation, 1 µg purified antibody or 2 µl antiserum was added to a maximum of 1 mg total cellular proteins for at least 1 h at 4°C, followed by incubation with Staphylococcus aureus particles (Pansorbin cells; Calbiochem-Novabiochem, Bad Soden, Germany) or S. aureus particles preincubated with rabbit anti-mouse antibodies for 30 min at 4°C. The immunoprecipitates were washed four times in TNE and once in 10 mM Tris-HCl, pH 7.4. For immunoblotting, whole-cell lysates or precipitated proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinylidene difluoride membranes (ImmobilonP; Millipore, Bedford, MA). The membranes were incubated for 1 h at room temperature or at 4°C overnight in blocking buffer (PBS, 0.1% Tween 20, 5% [wt/vol] nonfat dry milk powder), followed by incubation with primary antibody diluted in blocking buffer for 1 hour or overnight. Immunoblot detection was performed as described by the manufacturer of the enhanced-chemiluminescence system (ECL; Amersham Pharmacia Biotech, Freiburg, Germany) and documented by autoradiography or by a Fuji LAS-1000 chemiluminescence detection system (Raytest, Straubenhardt, Germany).
An alternative protocol was used for some experiments (see Fig. 4). Cells were lysed in 50 mM HEPES, pH 7.5, 150 mM NaCl, 1 mM EDTA, 10 mM Na4P2O7, 10% glycerol, 1% Triton X-100 supplemented with inhibitors as indicated above. Immune complexes were precipitated using protein A-Sepharose CL-4B (Amersham Pharmacia Biotech, Freiburg, Germany) and washed with HNTG buffer (20 mM HEPES, pH 7.5, 150 mM NaCl, 0.1% Triton X-100, and 10% glycerol). After SDS-PAGE, the proteins were transferred to nitrocellulose membranes and NET-gelatin buffer (150 mM NaCl, 5 mM EDTA, pH 8.0, 50 mM Tris-HCl, pH 7.5, 0.05% Triton X-100, 2.5 g/liter gelatin) was used for all subsequent incubation and washing steps.
![]() View larger version (40K): [in a new window] |
FIG. 4. Phenotype of CBL cultures (donor 1749) infected with herpesvirus saimiri C488 (C488 wt) and recombinant viruses carrying wild-type sequences (M11 wt) or mutations within the Tip reading frame ( CSKH, mSH3B, and CSKH mSH3B). (A) Morphology documented by photography 5 weeks postinfection (no virus, C488 wt, and M11 wt as in reference 35). (B) Surface expression of CD3, CD4, and CD8 antigens 6 weeks after infection. The histograms show fluorescence intensity in logarithmic scale on the x axis and cell numbers in linear scale on the y axis. The open graphs represent negative isotype controls, and the solid graphs represent specific staining.
|
-32P]ATP (6,000 Ci/mmol; Amersham Biosciences, Freiburg, Germany). Flow cytometry. Transformed human T cells were analyzed by flow cytometry with antibodies for T-cell surface epitopes on a FACScalibur flow cytometer according to standard protocols. The directly labeled monoclonal antibodies (Cy-Chrome, fluorescein-isothiocyanate, or phycoerythrin conjugated) were specific for CD3 (Leu-4), CD4 (Leu-3a), and CD8 (Leu-2a). Directly labeled isotype-matched monoclonal antibodies were used as controls (all antibodies were from BD Biosciences, Heidelberg, Germany).
|
|
|---|
![]() View larger version (40K): [in a new window] |
FIG. 1. Interaction of Tip wt, as well as mSH3B and CSKH mutants, with Lck in T cells. (A) Lysates of monkey T cells transformed by wild-type herpesvirus saimiri C488 (HVS C488 wt) or by the recombinant virus HVS/Tip mSH3B were immunoprecipitated (IP) with rabbit anti-Lck (Lck) or anti-Tip (Tip) antiserum as indicated, and an immune complex kinase assay was performed. Precipitation without specific antiserum () was used as a control. (B) Jurkat T cells were transiently transfected with plasmids encoding AU1-tagged Tip (Tip wt) or the mutants Tip CSKH ( CSKH) and Tip mSH3B (mSH3B) as indicated. The lysates were divided, and an immune complex kinase assay was performed using anti-CD4 (CD4), anti-Lck (Lck), or anti-AU1 (Tip) antibodies. Immunoprecipitation without specific antibodies () and nontransfected Jurkat cells (control) served as negative controls. Expression of Tip proteins was verified by Tip-specific immunoblotting on whole-cell lysates (IB -Tip). The positions of Lck and Tip proteins are given on the right; molecular mass markers in kDa are on the left.
|
To test for the relative roles of the SH3B and CSKH motifs in Lck interaction independently of the tyrosine phosphorylation of Tip that occurs upon coexpression of both proteins, we used an in vitro binding assay. For this purpose, COS-7 cells were individually transfected with Tip wt,
CSKH, mSH3B, or
CSKH mSH3B, as well as Lck wt and Lck
SH3. Lysates of transfected cells were adjusted for both equal total cellular protein content and equal Tip or Lck levels by the addition of lysates from nontransfected COS-7 cells. The binding of Tip and its mutants was assessed by Lck immunoprecipitation from mixed lysates, followed by an in vitro kinase assay and immunoblot detection of coprecipitated Tip proteins (Fig. 2). A correlation between phosphorylation and coprecipitation of Tip was observed in all samples. Therefore, phosphorylation of Tip and its mutants appeared to depend only on Lck binding and not the presence of specific residues within the CSKH or SH3B motifs. Wild-type Tip binding and phosphorylation were detected in Lck and to a lesser extent in Lck
SH3 precipitates, indicating that SH3-independent binding was detectable in this system. Relative to wild-type Tip, binding of the mutants Tip
CSKH and Tip mSH3B to wild-type Lck was reduced, demonstrating the modular nature and the cooperation of the LBD motifs. Interaction of Tip
CSKH with wild-type Lck, but not with the SH3 deletion mutant, indicated that SH3-independent binding relied on the CSKH motif, while comparable binding of Tip wild type and mSH3B to Lck
SH3 confirmed the SH3 specificity of the SH3B motif. The involvement of additional Tip sequences in Lck interaction under these experimental conditions was excluded by the double mutant Tip
CSKH mSH3B, which was devoid of any Lck binding activity.
![]() View larger version (68K): [in a new window] |
FIG. 2. In vitro binding of Tip wt, CSKH, mSH3B, and CSKH mSH3B to Lck. Lysates (500 µl/300 µg each) of untreated COS-7 cells () or COS-7 cells transfected with expression plasmids coding for Lck (Lck wt), SH3-deficient Lck (Lck SH3), Tip (wt), Tip CSKH ( CSKH), Tip mSH3B (mSH3B), or the double mutant Tip CSKH mSH3B ( + m) were mixed as indicated. Lck was immunoprecipitated from the mixtures with specific rabbit antibodies (IP -Lck). The precipitates were divided into two aliquots and subjected to an in vitro kinase assay (IVKA) and Tip-specific immunoblotting (IB -Tip). The presence of Tip in the lysates (12 µg total cellular protein/lane) was verified by immunoblotting. The positions of Lck and Tip proteins are given on the right; molecular mass markers are on the left. hc, immunoglobulin heavy chain.
|
CSKH, mSH3B, and
CSKH mSH3B. The mutant C488 mSH3B encodes the same proline-to-alanine substitutions in Tip as HVS/Tip mSH3B (21). Human CBL were infected with wild-type C488, cosmid-generated wild-type M11 control virus, or the recombinant Tip-mutated viruses and monitored for growth transformation as detailed in Materials and Methods. While uninfected control cells were not growing during the observation period, all infected cultures initially displayed spontaneous proliferation (see Fig. 5). Morphological differences among the cultures were documented 5 weeks postinfection, when most of the control cells were dead. Cultures infected with wild-type or
CSKH viruses contained aggregates of viable cells. These aggregates were much larger in the cultures infected with the mSH3B mutant virus. The double-mutant herpesvirus saimiri C488
CSKH mSH3B induced smaller aggregates, and these cultures contained large amounts of cell debris (Fig. 4A). Subsequent fluorescence-activated cell sorter analyses identified cells from all infected cultures as T cells expressing CD3, as well as CD4 and/or CD8, at their surfaces (Fig. 4B). Cultures infected with virus mutants lacking the CSKH motif stopped growing approximately 4 weeks after infection, while cells infected with the mSH3B virus ceased to proliferate only after 7 to 8 weeks (Fig. 5). These data suggest that viruses with mutations in the LBD of Tip retain their capability for initial T-cell stimulation, which is extended in the presence of the CSKH motif. However, none of the LBD mutant viruses supported long-term T-cell proliferation. Thus, growth transformation of human T lymphocytes by herpesvirus saimiri C488 depended on Tip-Lck interaction via both the SH3B and CSKH motifs. Mutation of either of these motifs resulted in loss of the transforming capacity.
![]() View larger version (20K): [in a new window] |
FIG. 3. Construction of recombinant herpesvirus saimiri C488 CSKH, mSH3B, and CSKH mSH3B. Mutated Tip-coding DNA fragments were introduced into plasmid pSTBlueStpCY114HN. The altered Bst1107I fragments from pSTBlue were then reinserted into the Bst1107I-digested cosmid 331 Bst1107I. The resulting cosmids were linearized and cotransfected, together with cosmids 261, 291, 112, and 79, into permissive OMK cells. Recombinant virus from the culture supernatant was amplified by infection of OMK cells.
|
![]() View larger version (24K): [in a new window] |
FIG. 5. T-cell transformation assay with herpesvirus saimiri C488 wild type (C488 wt and M11 wt), CSKH, mSH3B, and CSKH mSH3B. Stimulated human CBL were infected and cultured in the presence of exogenous IL-2. Proliferation was monitored by automated cell counting, and total cell numbers were calculated as outlined in Materials and Methods. The median values and standard deviation (error bars) of each time point were determined from three independent donors. C488 wt, wild-type isolate; M11 wt, wild type reconstituted from cosmids.
|
![]() View larger version (58K): [in a new window] |
FIG. 6. Lck binding and tyrosine phosphorylation of Tip Y/F mutants in T cells. Jurkat T cells were transfected with plasmids coding for Tip (wt), individual point mutants of Tip (Y114F, Y127F, and Y155F), HA-tagged Tip (HA-wt), or HA-tagged Tip with Y/F mutations at positions 94, 114, and 155 (HA-FFYF). The cells were harvested and lysed 24 h after transfection. (A) Tip was immunoprecipitated (IP) with a specific rabbit antiserum. (B) A guinea pig antiserum was used to precipitate Lck. Tyrosine-phosphorylated proteins were detected by immunoblotting (IB) with the monoclonal antibody 4G10. The membranes were reprobed with the Tip-specific rabbit serum and with a monoclonal antibody directed against Lck. Immunoprecipitations without antibody (w/o ab) or without cell lysate (ab w/o lysate) served as controls. pY, phosphotyrosine; pTip, tyrosine-phosphorylated Tip.
|
![]() View larger version (19K): [in a new window] |
FIG. 7. T-cell transformation assay with reconstituted herpesvirus saimiri wild-type (wt) and the virus expressing Tip with a mutation at position 127 (Y127F). Stimulated human CBL from 10 different donors were infected, and proliferation in the presence or absence of IL-2 was monitored by automated cell counting. An experiment was considered successful when viable cells were still present 15 weeks after infection when total cell numbers were determined as outlined in Materials and Methods. Diamonds, cell numbers of individual samples; horizontal lines, geometrical mean values.
|
|
|
|---|
We now asked what was the role of the individual Tip-Lck interaction sites in growth transformation of primary human T cells, a feature unique to herpesvirus saimiri subgroup C strains. Although residual Lck binding was observed when either the CSKH or SH3B sequence was mutated, both motifs in the LBD of Tip were found to be essential for transformation in this system. The enhanced initial proliferation of cells infected with the mSH3B recombinant virus suggests a specific activating function, most likely mediated by binding of the CSKH motif to the kinase domain of Lck. A contribution of Lck-SH2 interaction to Tip-Lck binding was not detectable in our assay system, but mutation of the respective tyrosine residue Y127 abrogated transformation in the absence of exogenous IL-2. Thus, in contrast to published data on monkey cells (21), each of the Lck binding sites of Tip was required to transform human T cells in vitro. The discrepancy may be due, at least in part, to the cell systems used; human T cells are susceptible to herpesvirus saimiri subgroup C strains only (5), while common marmosets and their isolated lymphocytes are also targeted by subgroup A and, to a certain extent, subgroup B strains (16, 18, 64). This possibility is supported by the failure to transform human T cells with mutant C488 mSH3B (Fig. 5), as well as with HVS/Tip mSH3B, generated by J. U. Jung and coworkers (21).
The differences in the susceptibilities of human and monkey T cells may be linked to differences in the regulation of Lck and other Src family kinases. This is most obvious in the squirrel monkey, the natural host of herpesvirus saimiri, where T-cell stimulation does not result in Lck activation and the virus persists without causing disease (25, 28). In contrast, common marmosets (Callithrix jacchus) and cottontop tamarins (Saguinus oedipus) are sensitive to herpesvirus saimiri subgroup A and B strains, whose oncoproteins interact with the SH2 domain of Src (12, 36, 46) but seem to be unable to replace StpC and Tip in human T-cell transformation (A. Ensser, unpublished data). In contrast, such a substitution is achieved by Tio, the oncoprotein of herpesvirus ateles, which interacts with the SH2 and SH3 domains of Src family kinases (1, 2). Transformation of human cells by Tio recombinant viruses depends on both the SH3 binding motif and the tyrosine phosphorylation site in Tio (3). Thus, in the marmoset system, a weak Tip-Lck interaction via one Lck-interacting domain of Tip may be sufficient for growth transformation in culture and lymphoma induction in vivo, while growth regulation of human T cells requires a complex interaction of viral oncoproteins with Src family kinases, like Lck.
The conserved binding of Tip and related viral oncoproteins to SH2 domains of Src family kinases suggests a functional relevance for this type of interaction. The role of the putative SH2 binding site of Tip, tyrosine residue 127, in human T-cell transformation under IL-2-free conditions indicated an influence on IL-2 signaling pathways, which had already been suggested for wild-type Tip in earlier studies (47, 49). However, as combined mutations of Y127 with CSKH or SH3B were not tested, additional functions of Tip Y127 may have been masked in our analyses. In addition, residues surrounding Tip Y127, as well as the CSKH and SH3B motifs, are well conserved among different herpesvirus saimiri subgroup C isolates (22, 28) and, except for the CSKH motif, in herpesvirus ateles (2, 3). The implicit selective pressure for all Lck interaction sites points to an essential function in the natural host whose nature remains enigmatic.
The major question raised by our findings addresses the effectors acting downstream of the Tip-Lck complex in human T-cell transformation. As detailed in the introduction, STAT activation by Tip appeared to be a promising candidate. We therefore performed transformation experiments with a recombinant virus expressing the Tip mutant Y114F, which is no longer able to induce STAT1 and STAT3 activity, and found that abrogation of STAT induction by Tip rather enhances the growth of human T cells transformed by herpesvirus saimiri C488 (35). An explanation for the increased proliferation rates might be provided by enhanced binding and activation of Lck by Tip carrying a tyrosine-to-serine mutation at position 114 (29). However, we did not detect any differences in Lck binding for Tip Y114F (Fig. 6). Furthermore, a Tip Y114 phosphopeptide exhibited no significant affinity for the SH2 domain of Lck (4). Taken together, current data do not provide evidence for an essential role of Tip Y114 or STAT1/3 activation in human T-cell transformation by herpesvirus saimiri C488.
Another effect of Tip that has to be considered for its involvement in viral transformation is the downregulation of surface receptor molecules. High levels of stable or transient Tip expression in Jurkat T cells, but not in an Lck-negative Jurkat variant, led to modulation of the TCR-CD3 complex and of the coreceptor CD4 (40, 59). This process is enhanced when tyrosine residue 114 of Tip is replaced by serine and involves binding of Tip to the lysosomal targeting protein p80 (58, 59). However, the lower levels of Tip expression in herpesvirus saimiri C488-transformed cells do not seem to be sufficient for overt receptor downregulation. Surface expression of CD4 is normal, and CD3 is only modestly reduced in lymphocytes infected with herpesvirus saimiri C488 wild type compared to transformation-incompetent mutants (Fig. 4). Another minor decrease in CD3 expression is observed in C488-Y114F cells relative to wild-type transformed cells (35). Therefore, only a small fraction of TCR/CD3 complexes is likely to be endocytosed and degraded in virus-transformed lymphocytes and may not have a detectable impact on Lck expression levels and on basal, as well as inducible, cellular protein tyrosine phosphorylation, which was strongly reduced upon Tip overexpression (29, 40, 58, 59). Likewise, the Tip-induced block in signaling from Lck to ZAP70 (11) may not affect all TCR-CD3 complexes on the surfaces of transformed cells. These assumptions are supported by one of the most intriguing properties of human T-cell clones transformed by herpesvirus saimiri C488, the maintenance of antigen specificity and responsiveness (9, 15, 65). The transformed T-cell clones also display increased basal levels of cellular protein tyrosine phosphorylation relative to their noninfected parental lines (67). In conclusion, Tip-mediated downregulation of TCR expression and signaling is not likely to be essential for T-cell transformation.
Modulation of the TCR-CD3 complex from the surfaces of Jurkat T cells is an Lck-dependent process that may be induced by the expression of constitutively active Lck (19). Therefore, TCR-CD3 downregulation by Tip indicates Lck activation in T cells expressing the viral oncoprotein. While negative regulatory downstream effects seem to mask this activation in T cells overexpressing Tip, it has been demonstrated in several other cellular and in vitro systems (31, 42, 48, 51, 67). Dependent on the presence of both the CSKH or SH3B motifs, Tip is able to activate Lck in an in vitro assay system even when the regulatory tyrosine residues Y394 and Y505 of Lck are mutated (33). This novel type of Lck regulation by simultaneous binding of both LBD motifs may result in an altered substrate specificity of the kinase, contributing to the abrogation of ZAP70 phosphorylation (11). More importantly, this dysregulation may link Tip-bound Lck to alternative downstream effectors, which may account for the substitution of ZAP70 function by herpesvirus saimiri C488 (54). Therefore, the characterization of substrates specific for Tip-complexed Lck will be an important step to identify cellular proteins mediating the essential functions downstream of Tip-Lck interaction.
In summary, our data provide evidence that a complex interaction between the viral oncoprotein Tip and the T-cell tyrosine kinase Lck is required for transformation of human T cells by herpesvirus saimiri C488. However, known downstream targets of Tip, STAT activation, TCR modulation, and blocking of ZAP70 activation, can be excluded as mediators of the transforming effects. Consequently, future investigations will have to address in more detail the Lck signal transduction pathways in herpesvirus saimiri-transformed human T cells.
This project was supported by the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 466 and Graduiertenkolleg 1071), the Interdisciplinary Center for Clinical Research (IZKF) (Genesis, Diagnostics and Therapy of Inflammation Processes) at the Friedrich-Alexander-Universität Erlangen-Nürnberg, the Academy of Sciences and Literature (Mainz), the Wilhelm Sander-Stiftung, and the German-Israeli Foundation (project 674/2000).
Present address: New England Primate Research Center, Harvard Medical School, One Pine Hill Drive, Southborough, MA 01772-9102. ![]()
Armin Ensser and Brigitte Biesinger made equal contributions to this work. ![]()
|
|
|---|
B activation and lymphocyte transformation by herpesvirus saimiri STP. J. Virol. 73:3913-3919.
B activity and interleukin-2 gene expression. Virology 279:325-338.[CrossRef][Medline]
B activation. J. Biol. Chem. 279:13469-13477.This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»